- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 15, 2025 | 16.6M sh |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $50.87M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $50.5M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $67.88M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $66.68M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 16.57K sh |
| Capex | Q1 2025 · Mar 31, 2024 | $11K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$3.14M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $6.18M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2023 | $7.62M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $17.82M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $5.1M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.14 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.14 |
| Net Income | Q1 2025 · Mar 31, 2024 | −$2.31M |
| Revenue | Q1 2025 · Mar 31, 2024 | $40.08M |